Atlas Trials

Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis

Clinical trial NCT00408629 · COMPLETED

Trial details

NCT number
NCT00408629
Sponsor
Abbott
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2006-11-01
Primary completion
2010-03-01
Enrollment
518

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.